These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

354 related articles for article (PubMed ID: 8263773)

  • 1. Tyrphostin attenuates platelet-derived growth factor-induced contraction in aortic smooth muscle through inhibition of protein tyrosine kinase(s).
    Sauro MD; Thomas B
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1119-25. PubMed ID: 8263773
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Decreased sensitivity of aorta from hypertensive rats to vasorelaxation by tyrphostin.
    Sauro MD; Thomas B
    Life Sci; 1993; 53(22):PL371-6. PubMed ID: 8231645
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Serotonin stimulates protein tyrosyl phosphorylation and vascular contraction via tyrosine kinase.
    Watts SW; Yeum CH; Campbell G; Webb RC
    J Vasc Res; 1996; 33(4):288-98. PubMed ID: 8695753
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of EGF-induced vasoconstriction in isolated rabbit aortic rings with the tyrosine kinase inhibitor RG50864.
    Merkel LA; Rivera LM; Colussi DJ; Perrone MH
    Biochem Biophys Res Commun; 1993 May; 192(3):1319-26. PubMed ID: 7685166
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structurally novel antihypertensive compound, McN-5691, is a calcium channel blocker in vascular smooth muscle.
    Flaim SF; Gleason MM; Hedberg A; Shank RP; McCullough JR; Gill A; Damiano BP; Brannan MD; Carson JR
    J Pharmacol Exp Ther; 1991 Jan; 256(1):279-88. PubMed ID: 1846419
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Involvement of tyrosine phosphorylation in endothelin-1-induced calcium-sensitization in rat small mesenteric arteries.
    Ohanian J; Ohanian V; Shaw L; Bruce C; Heagerty AM
    Br J Pharmacol; 1997 Feb; 120(4):653-61. PubMed ID: 9051304
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo effects of angiotensin II on vascular smooth muscle contraction and blood pressure are mediated through a protein tyrosine-kinase-dependent mechanism.
    Sauro MD; Sudakow R; Burns S
    J Pharmacol Exp Ther; 1996 Jun; 277(3):1744-50. PubMed ID: 8667246
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of protein tyrosine kinase on regulation of trabecular meshwork and ciliary muscle contractility.
    Wiederholt M; Groth J; Strauss O
    Invest Ophthalmol Vis Sci; 1998 May; 39(6):1012-20. PubMed ID: 9579481
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of inhibition by heparin of PDGF stimulated MAP kinase activation in vascular smooth muscle cells.
    Pukac LA; Carter JE; Ottlinger ME; Karnovsky MJ
    J Cell Physiol; 1997 Jul; 172(1):69-78. PubMed ID: 9207927
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tyrosine kinases in norepinephrine-induced contraction of vascular smooth muscle.
    Abebe W; Agrawal DK
    J Cardiovasc Pharmacol; 1995 Jul; 26(1):153-9. PubMed ID: 7564357
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro pharmacological characterization of PD 166285, a new nanomolar potent and broadly active protein tyrosine kinase inhibitor.
    Panek RL; Lu GH; Klutchko SR; Batley BL; Dahring TK; Hamby JM; Hallak H; Doherty AM; Keiser JA
    J Pharmacol Exp Ther; 1997 Dec; 283(3):1433-44. PubMed ID: 9400019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vascular effects of 15-F2t-isoprostane in spontaneously hypertensive rats.
    Marlière S; Cracowski JL; Hakim A; Stanke-Labesque F; Hoffmann P; Bessard G
    Can J Physiol Pharmacol; 2005 Jun; 83(6):453-8. PubMed ID: 16049544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dissociation of angiotensin II-stimulated activation of mitogen-activated protein kinase kinase from vascular contraction.
    Watts SW; Florian JA; Monroe KM
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1431-8. PubMed ID: 9732408
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of cell growth: effects of the tyrosine kinase inhibitor CGP 53716.
    Major TC; Keiser JA
    J Pharmacol Exp Ther; 1997 Oct; 283(1):402-10. PubMed ID: 9336349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Signaling mechanisms of basic fibroblast growth factor in arterial cells from genetically hypertensive rat.
    Zhu DL; Hérembert T; Caruelle D; Caruelle JP; Marche P
    Am J Hypertens; 1994 Apr; 7(4 Pt 1):351-6. PubMed ID: 8031551
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective role of a novel erythrocyte-derived depressing factor on blood vessels of renovascular hypertensive rats.
    Pang H; Wen YY; Ma N; Wang YT; Shi L
    Clin Exp Pharmacol Physiol; 2007; 34(5-6):393-8. PubMed ID: 17439406
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Peroxisome proliferator-activated receptor gamma ligands inhibit Rho/Rho kinase pathway by inducing protein tyrosine phosphatase SHP-2.
    Wakino S; Hayashi K; Kanda T; Tatematsu S; Homma K; Yoshioka K; Takamatsu I; Saruta T
    Circ Res; 2004 Sep; 95(5):e45-55. PubMed ID: 15308580
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potent vasoconstrictor actions of cyclopiazonic acid and thapsigargin on femoral arteries from spontaneously hypertensive rats.
    Nomura Y; Asano M; Ito K; Uyama Y; Imaizumi Y; Watanabe M
    Br J Pharmacol; 1997 Jan; 120(1):65-73. PubMed ID: 9117100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Blockade of DNA synthesis induced by platelet-derived growth factor by tranilast, an inhibitor of calcium entry, in vascular smooth muscle cells.
    Nie L; Mogami H; Kanzaki M; Shibata H; Kojima I
    Mol Pharmacol; 1996 Oct; 50(4):763-9. PubMed ID: 8863820
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Extracellular signal-regulated kinase1/2 in contraction of vascular smooth muscle.
    Tsai MH; Jiang MJ
    Life Sci; 2005 Jan; 76(8):877-88. PubMed ID: 15589965
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.